BioSpace News Archive

The St. Elizabeth Healthcare Clinical Research Institute, an early contributor to the COVID-19 and Cancer Consortium (CCC19), is honored to collaborate in the groundbreaking CCC19 study focusing on outcomes for COVID-19 patients with cancer

Despite being known as “good” fat, excess unsaturated fatty acids may prove deadly for patients who develop, pancreatitis, COVID-19 and other acute illnesses. A new Mayo Clinic study led by Dr. Vijay Singh underscores the potential value of the lead therapeutic compound, RABI-767 in development by Lamassu Pharma, LLC

ZAP Surgical Announces Future Installation of Novel Non-Invasive Brain Tumor Treatment System in Munich, Germany European CyberKnife Center to be Among the First Providers in the World to Offer the Latest Advance in Gyroscopic Radiosurgery

Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., strongly welcomes the Government of Canada’s commitment in the April 19, 2021 federal budget to support Canada’s life science sector.

Formalization of the current relationship will allow PharmaDrug to expedite development timelines by leveraging SwRI’s existing Cepharanthine preclinical data sets and considerable manufacturing know-how.

The Restructuring Agreement has been approved by the Board of Directors for both organizations and is now subject to the approval of CVR Medical’s shareholders and the TSX Venture Exchange (the “TSXV”).

- Efficacy and Product Integration Testing Slated for Completion in Fall 2021 - Upon FDA Clearance the WellnessPro POD ™ Device Could Emerge as a Leading Chronic Pain drug-free choice to Opioids for Mass Market Retail Customers.

The Jerome Canady Research Institute for Advanced Biological and Technological Sciences, LLC (JCRI-ABTS) and US Medical Innovations, LLC (USMI) announced today that they have successfully completed Phase 1 in their Clinical Trial using Canady Helios™ Cold Plasma (CHCP) for the treatment of recurrent and stage 4 solid tumors (IDE #G190195).

AlphaGroup is proud to announce the addition of Gregory Bezkorovainy, MA, as Vice President Scientific Director of AlphaScientia to lead its scientific team.

To view the full announcement, including downloadable images, bios, and more, click here.